Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Adam D Cohen

1-50 of 64 results

View this query on the Wikidata Query Service
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

scientific article
Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma

scientific article
Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation

scientific article
OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis.

scientific article published on 04 May 2009
Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity

scientific article
Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma.

scientific article
Modulating the immune response to genetic immunization

scientific article published on 01 December 1998
A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma.

scientific article
NCCN clinical practice guidelines in oncology: multiple myeloma

scientific article published on 01 October 2009
B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma

scientific article published on 21 March 2019
Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.

scientific article published in October 2007
Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study.

scientific article published on 17 September 2015
Combination immune therapies to enhance anti-tumor responses by NK cells.

scientific article published on 23 December 2013
HIV-1 DNA vaccines and chemokines.

scientific article published in October 1999
Systemic Light-Chain Amyloidosis: Advances in Diagnosis, Prognosis, and Therapy

scientific article published on January 1, 2010
Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.

scientific article published on 19 April 2018
Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.

scientific article published in July 2000
Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trial

scientific article published on 01 January 1999
Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone

scientific article published on 04 August 2008
Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis

scientific article published on 28 December 2017
Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial

scientific article published on 12 November 2018
CRISPR-engineered T cells in patients with refractory cancer

scientific article published on 07 February 2020
Multiple myeloma

scientific article published on 01 October 2011
Antibody-drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study

scientific article published on 20 March 2019
Anti-GITR antibodies--potential clinical applications for tumor immunotherapy

scientific article published on December 1, 2010
Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease

scientific article published on 01 July 2002
High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease.

scientific article published on 23 June 2008
A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis.

scientific article published on 26 May 2017
Systemic and mucosal immunity is elicited after both intramuscular and intravaginal delivery of human immunodeficiency virus type 1 DNA plasmid vaccines to pregnant chimpanzees.

scientific article published in October 1999
Classifying ultra-high risk smoldering myeloma.

scientific article
Systemic AL amyloidosis due to non-Hodgkin's lymphoma: an unusual clinicopathologic association.

scientific article published in February 2004
Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma.

scientific article
Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma.

scientific article published on 6 June 2015
The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanisms.

scientific article published on 16 June 2017
DNA vaccines against cancer.

scientific article published on June 2006
CAR T Cells and Other Cellular Therapies for Multiple Myeloma: 2018 Update

scientific article published on 01 May 2018
Immune rejection of mouse tumors expressing mutated self.

scientific article published on 7 April 2009
Detection of intra-tumor self antigen recognition during melanoma tumor progression in mice using advanced multimode confocal/two photon microscope

scientific article (publication date: 2011)
NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors.

scientific article published on 19 May 2017
Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma

scientific article published on 05 November 2018
A Phase 1 and 2 study of Filanesib alone and in combination with low-dose dexamethasone in relapsed/refractory multiple myeloma

scientific article published on 17 August 2017
DNA immunization against tissue-restricted antigens enhances tumor immunity after allogeneic hemopoietic stem cell transplantation.

scientific article published on September 2006
Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma

scientific article published on 21 February 2019
Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma

scientific article published on March 9, 2015
Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease.

scientific article published on 23 September 2011
Chimeric antigen receptor T cell immunotherapy for multiple myeloma: A review of current data and potential clinical applications

scientific article published on 25 February 2019
Enhanced responses to tumor immunization following total body irradiation are time-dependent

scientific article
T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma

scientific article published on 01 October 2019
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

scientific article
Prior exposure to superantigen can inhibit or exacerbate autoimmune encephalomyelitis: T-cell repertoire engaged by the autoantigen determines clinical outcome

scientific article published on 01 December 1996

Paulina is supported by:

About Paulina

Help